CYB5R3
Basic information
Region (hg38): 22:42615730-42720870
Previous symbols: [ "DIA1" ]
Links
Phenotypes
GenCC
Source:
- methemoglobinemia due to deficiency of methemoglobin reductase (Strong), mode of inheritance: AR
- hereditary methemoglobinemia (Supportive), mode of inheritance: AR
- methemoglobinemia (Definitive), mode of inheritance: AR
- methemoglobinemia due to deficiency of methemoglobin reductase (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Methemoglobinemia due to methemoglobin reductase deficiency | AR | Biochemical; Pharmacogenomic | Some forms of disease are responsive to medical therapy (eg, with ascorbic acid), though neurological manifestations in severe forms have not been described as being impacted by this type of management; In treatment with certain medications (eg, Dapsone), genotyping may assist in the prevention and/or early treatment of adverse reactions | Biochemical; Hematologic; Neurologic | 21011935; 18861684; 1207738; 4063522; 3539237; 1707593; 8427971; 7668255; 7718898; 9266404; 9695975; 10874300; 12803131; 15921385; 15390276; 17964195; 18202104; 18343696; 18820099; 18318771; 19579085; 19997042; 21328435; 22627575; 22658170; 22797852 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (145 variants)
- Deficiency_of_cytochrome-b5_reductase (54 variants)
- Inborn_genetic_diseases (39 variants)
- not_specified (24 variants)
- METHEMOGLOBINEMIA,_TYPE_I (12 variants)
- CYB5R3-related_disorder (11 variants)
- METHEMOGLOBINEMIA,_TYPE_II (10 variants)
- Central_core_myopathy (4 variants)
- Hereditary_methemoglobinemia (3 variants)
- Neurodevelopmental_delay (1 variants)
- Intellectual_disability (1 variants)
- CYB5R3_POLYMORPHISM (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CYB5R3 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000000398.7. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 28 | 31 | ||||
missense | 13 | 96 | 123 | |||
nonsense | 7 | |||||
start loss | 2 | 2 | ||||
frameshift | 3 | |||||
splice donor/acceptor (+/-2bp) | 4 | |||||
Total | 17 | 16 | 99 | 33 | 5 |
Highest pathogenic variant AF is 0.000120832
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CYB5R3 | protein_coding | protein_coding | ENST00000361740 | 9 | 31729 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000192 | 0.978 | 125715 | 0 | 33 | 125748 | 0.000131 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.419 | 222 | 205 | 1.08 | 0.0000136 | 2176 |
Missense in Polyphen | 80 | 78.119 | 1.0241 | 862 | ||
Synonymous | 0.119 | 80 | 81.4 | 0.983 | 0.00000547 | 639 |
Loss of Function | 2.03 | 9 | 18.4 | 0.489 | 0.00000104 | 188 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000185 | 0.000185 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000326 | 0.000326 |
Finnish | 0.000508 | 0.000508 |
European (Non-Finnish) | 0.0000880 | 0.0000879 |
Middle Eastern | 0.000326 | 0.000326 |
South Asian | 0.0000980 | 0.0000980 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Desaturation and elongation of fatty acids, cholesterol biosynthesis, drug metabolism, and, in erythrocyte, methemoglobin reduction.;
- Disease
- DISEASE: Methemoglobinemia CYB5R3-related (METHB-CYB5R3) [MIM:250800]: A form of methemoglobinemia, a hematologic disease characterized by the presence of excessive amounts of methemoglobin in blood cells, resulting in decreased oxygen carrying capacity of the blood, cyanosis and hypoxia. There are two types of methemoglobinemia CYB5R3-related. In type 1, the defect affects the soluble form of the enzyme, is restricted to red blood cells, and causes well-tolerated methemoglobinemia. In type 2, the defect affects both the soluble and microsomal forms of the enzyme and is thus generalized, affecting red cells, leukocytes and all body tissues. Type 2 methemoglobinemia is associated with mental deficiency and other neurologic symptoms. {ECO:0000269|PubMed:10807796, ECO:0000269|PubMed:12393396, ECO:0000269|PubMed:1400360, ECO:0000269|PubMed:15622768, ECO:0000269|PubMed:15953014, ECO:0000269|PubMed:1707593, ECO:0000269|PubMed:1898726, ECO:0000269|PubMed:7718898, ECO:0000269|PubMed:8119939, ECO:0000269|PubMed:9695975, ECO:0000269|PubMed:9886302}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Amino sugar and nucleotide sugar metabolism - Homo sapiens (human);Methylene Blue Pathway, Pharmacodynamics;Oxidation by Cytochrome P450;Neutrophil degranulation;Phase I - Functionalization of compounds;Vitamin C (ascorbate) metabolism;Biological oxidations;Vitamin B3 (nicotinate and nicotinamide) metabolism;Innate Immune System;Immune System;Metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors
(Consensus)
Recessive Scores
- pRec
- 0.282
Intolerance Scores
- loftool
- 0.0159
- rvis_EVS
- 0.51
- rvis_percentile_EVS
- 80.2
Haploinsufficiency Scores
- pHI
- 0.206
- hipred
- N
- hipred_score
- 0.499
- ghis
- 0.564
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.532
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cyb5r3
- Phenotype
Gene ontology
- Biological process
- cholesterol biosynthetic process;blood circulation;L-ascorbic acid metabolic process;neutrophil degranulation;oxidation-reduction process
- Cellular component
- extracellular region;cytoplasm;mitochondrion;mitochondrial outer membrane;endoplasmic reticulum;endoplasmic reticulum membrane;lipid droplet;hemoglobin complex;membrane;azurophil granule lumen
- Molecular function
- cytochrome-b5 reductase activity, acting on NAD(P)H;protein binding;AMP binding;ADP binding;NAD binding;FAD binding